Ropharma SA

As of December 31, 2024, Ropharma SA carries a market capitalization of 82.31M, placing it among publicly traded companies globally. Its enterprise value stands at 238.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Ropharma SA has 511.27M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Ropharma SA maintains a current ratio of 1.05, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Ropharma SA's stock has gained approximately 50.90% over the past 52 weeks. The 50-day moving average sits at 0.21, while the 200-day moving average is 0.21.

As of December 31, 2024, Ropharma SA holds 19.90M in cash and equivalents against 162.42M in total debt, resulting in a net debt position of 47.87M. Total book value stands at 245.23M, with working capital of 30.67M providing operational flexibility.

Ropharma SA's most recent stock split took place on July 3, 2013 with a 4:7 split ratio.